(Q84137154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Phase I study of TAC-101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Takuji Okusaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Hideki Ueno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Masafumi Ikeda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Yoriko Takezako

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Chigusa Morizane

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

18 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1524-1530

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

Sorafenib in advanced hepatocellular carcinoma

1 February 2020

cites work

1 reference

12 December 2020

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid inhibits angiogenesis in colon cancer through reduced expression of vascular endothelial growth factor

1 reference

12 December 2020

A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals

1 reference

12 December 2020

Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancer

1 reference

12 December 2020

Hepatocellular carcinoma: the need for progress.

1 reference

12 December 2020

TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span.

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02334.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22587457%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1 reference